Psychological determinants of drug adherence and severity of hypertension in patients with apparently treatment-resistant vs. controlled hypertension

被引:6
|
作者
Georges, Coralie M. G. [1 ]
Ritscher, Sabrina [2 ]
Pappaccogli, Marco [3 ]
Petit, Geraldine [4 ,5 ]
Lopez-Sublet, Marilucy [1 ,6 ]
Bapolisi, Achille [4 ,5 ,7 ,8 ]
Di Monaco, Silvia [3 ]
Wallemacq, Pierre [9 ,10 ]
Rabbia, Franco [3 ]
Toennes, Stefan W. [2 ]
de Timary, Philippe [4 ,5 ]
Persu, Alexandre [1 ,11 ]
机构
[1] Catholic Univ Louvain, Clin Univ St Luc, Dept Cardiol, Brussels, Belgium
[2] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Inst Legal Med, Dept Forens Toxicol, Frankfurt, Germany
[3] AOU Citta Salute & Sci, Dept Med Sci, Internal Med & Hypertens Div, Turin, Italy
[4] Catholic Univ Louvain, Clin Univ St Luc, Adult Psychiat Dept, Brussels, Belgium
[5] Catholic Univ Louvain, Clin Univ St Luc, Inst Neurosci, Brussels, Belgium
[6] CHU Avicenne AP HP, ESH Hypertens Excellence Ctr, Dept Internal Med, Bobigny, France
[7] Univ Catholique Bukavu, Bukavu, DEM REP CONGO
[8] Hop Prov Gen Bukavu, Bukavu, DEM REP CONGO
[9] Clin Univ St Luc, Clin Chem Dept, Brussels, Belgium
[10] Catholic Univ Louvain, Ctr Toxicol & Appl Pharmacol, Brussels, Belgium
[11] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Cardiovasc Res, Brussels, Belgium
关键词
Resistant hypertension; drug adherence; psychological profile; expression of emotions; somatisation; EMOTION REGULATION; SOMATIZATION; ALEXITHYMIA; VALIDATION; MEDICATION;
D O I
10.1080/08037051.2022.2099346
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose In a pilot study including 35 patients with apparently treatment-resistant hypertension (ATRH), we documented associations between psychological profile, drug adherence and severity of hypertension. The current study aims to confirm and expand our findings in a larger and more representative sample of patients with ATRH, using controlled hypertensive patients as the comparator. Materials and Methods Patients with ATRH were enrolled in hypertension centres from Brussels and Torino. The psychological profile was assessed using five validated questionnaires. Drug adherence was assessed by high-performance liquid chromatography-tandem mass spectrometry analysis of urine samples, and drug resistance by 24-hour ambulatory blood pressure was adjusted for drug adherence. Results The study sample totalised 144 patients, including 81 ATRH and 63 controlled hypertensive patients. The mean adherence level was significantly lower in the "resistant" group (78.9% versus 92.7% in controlled patients, p-value = .022). In patients with ATRH, independent predictors of poor drug adherence were somatisation, smoking and low acceptance level of difficult situations, accounting for 41% of the variability in drug adherence. Independent predictors of severity of hypertension were somatisation, smoking, more frequent admissions to the emergency department and low acceptation, accounting for 63% of the variability in the severity of hypertension. In contrast, in patients with controlled hypertension, the single predictors of either drug adherence or severity of hypertension were the number of years of hypertension and, for the severity of hypertension, alcohol consumption, accounting for only 15-20% of the variability. Conclusion Psychological factors, mostly related to somatisation and expression of emotions are strong, independent predictors of both drug adherence and severity of hypertension in ATRH but not in controlled hypertensive patients. Plain language summary This study included 144 patients with Apparently-Treatment Resistant (ATRH) or controlled Hypertension: Patients with ATRH were more often poorly adherent to antihypertensive treatment than controlled hypertensive patients. In patients with ARTH but not patients with controlled hypertension, psychological traits were strong, independent predictors of drug adherence and severity of hypertension, over and above demographic and health-related factors. In patients with ATRH, the tendency to somatize, i.e. expressing somatic symptoms that cannot be adequately explained by organic findings was the most potent predictor of both poor drug adherence and severity of hypertension. These patients also often presented alterations in the expression of emotions. It may be hypothesised that subjects who have difficulties identifying and expressing emotions with words will express them by physical complaints, and, in the mid-long term, might develop overt diseases. In addition to more classical lifestyle and drug management and irrespective of their drug adherence level, patients with ATRH may benefit in priority from psychological evaluation and interventions. However, this needs to be studied in an interventional trial in the future.
引用
收藏
页码:169 / 177
页数:9
相关论文
共 50 条
  • [41] Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease
    Akihiro Tsuchimoto
    Shigeru Tanaka
    Hiromasa Kitamura
    Hiroto Hiyamuta
    Kazuhiko Tsuruya
    Takanari Kitazono
    Toshiaki Nakano
    Clinical and Experimental Nephrology, 2022, 26 : 1100 - 1110
  • [42] Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease
    Tsuchimoto, Akihiro
    Tanaka, Shigeru
    Kitamura, Hiromasa
    Hiyamuta, Hiroto
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    Nakano, Toshiaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (11) : 1100 - 1110
  • [43] HAEMODYNAMIC CHANGES IN PATIENTS WITH TREATMENT-RESISTANT HYPERTENSION AFTER RENAL SYMPATHETIC DENERVATION COMPARED TO INDIVIDUALIZED DRUG THERAPY
    Bergo, K.
    Larstorp, A. C. K.
    Hoieggen, A.
    Hjornholm, U. P.
    Rostrup, M.
    Elmula, F. E. M. Fadl
    JOURNAL OF HYPERTENSION, 2017, 35 : E305 - E305
  • [44] Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis
    Vareta, Georgia
    Georgianos, Panagiotis, I
    Vaios, Vasilios
    Sgouropoulou, Vasiliki
    Georgianou, Eleni, I
    Leivaditis, Konstantinos
    Mavromatidis, Konstantinos
    Dounousi, Evangelia
    Papagianni, Aikaterini
    Balaskas, Elias, V
    Zebekakis, Pantelis E.
    Liakopoulos, Vassilios
    AMERICAN JOURNAL OF HYPERTENSION, 2022, 35 (11) : 918 - 922
  • [45] MRI POTENTIAL FOR PREDICTION OF THE ANTIHYPERTENSIVE EFFECT OF RFA IN PATIENTS WITH TREATMENT-RESISTANT HYPERTENSION
    Sukhareva, Anna
    Falkovskaya, Alla
    Baev, Andrey E.
    Mochula, Olga V.
    Maksimova, Alexandra S.
    Ryumshina, Nadezhda I.
    Shelkovnikova, Tatyana A.
    Zyubanova, Irina V.
    Tsoi, Ekaterina I.
    Manukyan, Musheg A.
    Mordovin, Viktor F.
    Ussov, Vladimir Yu
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E286 - E286
  • [46] Patients with treatment-resistant hypertension report increased stress and anxiety: a worldwide study
    Schmieder, Roland E.
    Grassi, Guido
    Kjeldsen, Sverre E.
    JOURNAL OF HYPERTENSION, 2013, 31 (03) : 610 - 615
  • [47] Home-based blood pressure monitoring vs. drug adherence monitoring in hypertension.
    Debusk, RF
    Miller, NH
    Rudd, P
    Kaufman, J
    Alexander, P
    Li, WW
    Greenwald, G
    CIRCULATION, 2001, 104 (17) : 606 - 606
  • [48] Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension
    Jacobs, Lotte
    Persu, Alexandre
    Huang, Qi-Fang
    Lengele, Jean-Philippe
    Thijs, Lutgarde
    Hammer, Frank
    Yang, Wen-Yi
    Zhang, Zhen-Yu
    Renkin, Jean
    Sinnaeve, Peter
    Wei, Fang-Fei
    Pasquet, Agnes
    Elmula, Fadl Elmula M. Fadl
    Carlier, Marc
    Elvan, Arif
    Wunder, Cora
    Kjeldsen, Sverre E.
    Toennes, Stefan W.
    Janssens, Stefan
    Verhamme, Peter
    Staessen, Jan A.
    BLOOD PRESSURE, 2017, 26 (06) : 321 - 331
  • [49] ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE DRUGS IN PATIENTS WITH RESISTANT HYPERTENSION RECEIVING OPTIMAL TREATMENT
    Kichou, B.
    Henine, N.
    Kichou, L.
    Said, M. Ait
    Benbouabdellah, M.
    Hacherouf, S.
    Mazeghrane, A.
    JOURNAL OF HYPERTENSION, 2018, 36 : E64 - E64
  • [50] Case of Chronic Indolent Pheochromocytoma That Caused Medically Controlled Hypertension but Treatment-Resistant Diabetes Mellitus
    Lee, HyunJung
    Dominiczak, Anna F.
    Jennings, Garry L. R.
    Cho, Eun Joo
    Lee, Hae-Young
    HYPERTENSION, 2017, 69 (05) : 740 - 746